Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 4;50(2):112.
doi: 10.1007/s11064-025-04361-7.

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity

Affiliations
Review

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity

Victória Linden de Rezende et al. Neurochem Res. .

Abstract

The aging process results in structural, functional, and immunological changes in the brain, which contribute to cognitive decline and increase vulnerability to neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and stroke-related complications. Aging leads to cognitive changes and also affect executive functions. Additionally, it causes neurogenic and neurochemical alterations, such as a decline in dopamine and acetylcholine levels, which also impact cognitive performance. The chronic inflammation caused by aging contributes to the impairment of the blood-brain barrier (BBB), contributing to the infiltration of immune cells and exacerbating neuronal damage. Therefore, rejuvenating therapies such as heterochronic parabiosis, cerebrospinal fluid (CSF) administration, plasma, platelet-rich plasma (PRP), and stem cell therapy have shown potential to reverse these changes, offering new perspectives in the treatment of age-related neurological diseases. This review focuses on highlighting the effects of rejuvenating interventions on neuroinflammation and the BBB.

Keywords: Aging; Blood–brain-barrier; Neuroinflammation; Rejuvenating therapies.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose.

References

    1. World Health Organization (2024) Ageing and health
    1. Cosco TD, Howse K, Brayne C (2017) Healthy ageing, resilience and wellbeing. Epidemiol Psychiatr Sci 26:579–583. https://doi.org/10.1017/S2045796017000324 - DOI - PubMed - PMC
    1. Janikiewicz J, Szymański J, Malinska D et al (2018) Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics. Cell Death Dis 9:332. https://doi.org/10.1038/s41419-017-0105-5 - DOI - PubMed - PMC
    1. van der Rijt S, Molenaars M, McIntyre RL et al (2020) Integrating the hallmarks of aging throughout the tree of life: a focus on mitochondrial dysfunction. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2020.594416 - DOI - PubMed - PMC
    1. López-Otín C, Blasco MA, Partridge L et al (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources